Challenges and Opportunities in Hematology: Live Advancing Healthcare Forum
Join SelectScience® for this exclusive, live roundtable discussion with leading experts in laboratory management. This session is kindly sponsored by Platinum CLINICAL24 sponsor, Scopio Labs.
The CLINICAL24 campaign has highlighted many challenges facing the clinical laboratory today. Key concerns include staffing vacancies and difficulties in implementing new technologies. During this unique live session, our panel of four thought-leaders will discuss their experiences of navigating and solving these challenges in the hematology field, while working at the forefront of laboratory management.
Learning outcomes summary:
- Understand how laboratory managers have managed centralization of services and other efficiency reorganizations
- Understand key considerations when implementing new technologies into the hematology lab
- Learn how managing staff vacancies in the lab and effective staff utilization helps to support the above activities
The discussion will be moderated by Sonia Nicholas, Managing Editor and Clinical Lead for SelectScience.
This Advancing Healthcare Forum is hosted as part of the global CLINICAL24 discussion.
Who should attend?
- Laboratory managers
- Laboratory directors
- Hematologists
- Laboratory scientists
- Healthcare professionals
- Clinicians/medical doctors
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes. This certificate is suitable for CPD self-certification in IBMS and HCPC portfolios.
Speakers
Daniel Dees is an experienced laboratory professional who specializes in bridging the knowledge gap between the clinical laboratory testing and clinical practice. Before earning his doctorate in clinical laboratory science, Dees served as a biomedical laboratory officer in the United States Army where he implemented multiple performance improvement projects at the laboratories. Daniel now holds the role of interim medical director for hematology and flow cytometry at Brigham and Women's Hospital clinical laboratory. He has been involved in the national committee responsible for the development of the body of knowledge for current and future doctors of clinical laboratory science. Dees serves a leading role in three integrated laboratory service groups within MGB to centralize and standardize testing in the areas of flow cytometry, hemoglobin evaluations and special coagulation.
Susan has presented on laboratory efficiency, automation and autoverification at symposiums in the US, Europe and China, including the American Association of Clinical Chemistry (AACC) Annual Meeting, Executive War College and at the National Chemistry meeting in China. She has co-authored abstracts and papers on laboratory efficiency, middleware implementation, utilization and optimization, and laboratory automation. She has worked with data management solutions for over 20 years and first implemented Autovalidation in her laboratory in 2003 for Chemistry, Hematology and Coagulation. Since that time, she has worked continually to optimize operations as new middleware capabilities have become available. The laboratory at Swedish Hospital has been a leader in the implementation of new instrumentation and cutting-edge technology and testing.
Dr Paul Cane is the Medical Director for Synnovis and Deputy Chielf Medicla Office for SYNLAB UK. He is responsible for maintaining high service quality and patient safety along with setting business development and innovation strategy. Paul has been working full time with Synnovis, since October 2021, and has played a key role in ensuring their transformation plan and new Blackfriars Hub Laboratory meets the needs of the population it serves. He has a keen interest in the service development and research opportunities that will be unlocked once service transformation is complete. Previously he was a clinical director for Viapath for 6 years and an NHS consultant at Guy's and St Thomas' Hospital for fifteen years.
Dr. Mathias Bruegel is currently Vice Director and Leading Senior Physician at the Institute of Laboratory Medicine, LMU Hospital Munich. Dr. Bruegel previously served as Senior Physician at the Institute of Laboratory Medicine; Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig. Dr. Bruegel has served as Principal Investigator on a number of scientific studies, including most recently, the 2024 Evaluation Study of Scopio Labs digital imaging platform X100HT. Dr. Bruegel has also been published in a wide range of scientific publications.
Moderator
